Delta Procalcitonin Is a Better Indicator of Infection Than Absolute Procalcitonin Values in Critically Ill Patients: A Prospective Observational Study
Table 1
Demographics, organ support, and outcome in the entire cohort.
Total
NI-group
I-group
value
Age (years)
65 (22.5)
67 (25.5)
65 (22)
0.772
Gender (M/F)
69/45
15/14
54/31
0.261
Body height (cm)
170 ()
167 ()
170 ()
0.766
Body weight (kg)
73 ()
80 ()
70 ()
0.345
SAPS II points
62.2 ± 20.5
62.7 ± 25.5
66.1 ± 18.6
0.513
SAPS II PM (%)
77.2 (52.1)
64.0 (75.9)
78.5 (42.1)
0.437
ICU days before enrollment
1 ()
1 ()
1 ()
0.669
Mechanical ventilation
80 (70.2%)
12 (41.4%)
68 (80.0%)
<0.001
Vasopressor therapy
69 (60.5%)
13 (44.8%)
56 (65.9%)
0.045
ICU LOS (day)
9 ()
8 ()
9 ()
0.089
ICU survival
84 (73.7%)
24 (82.8%)
60 (70.6%)
0.199
Hospital LOS (day)
17 ()
14 ()
19 ()
0.050
Hospital survival
67 (58.8%)
20 (68.9%)
47 (55.3%)
0.197
28-day survival
64 (56.1%)
19 (65.5%)
45 (52.9%)
0.239
Data are given as mean ± standard deviation or median (interquartile range) as appropriate. M: male; F: female; SAPS: simplified acute physiology score; PM: predicted mortality; ICU: intensive care unit; LOS: length of stay; mechanical ventilation and vasopressor therapy represent data at the day of enrollment.
